Biomarkers

Welcome! Our privacy policy has been updated for our soon to be launched, Xtalks Job Search. Stay tuned!

Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 2

Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 1

Optimizing Your CRO Selection Process for Pharmaceutical Drug Discovery

Evaluating Biomarkers During Clinical Trials for Immunotherapies: A Case Study on the Pioneer Project

November 27, 2019

NASH Clinical Drug Development: Imaging the Liver and Beyond

October 22, 2019

Six of the Latest NASH/NAFLD Webinars

Biomarkers and Clinical Risk Factors Combined for More Accurate Atrial Fibrillation Diagnosis

January 8, 2019

Expansion Cohorts in Early Development of Anticancer Agents

February 21, 2019

From Biomarkers to Companion Diagnostics: Advances in Immuno-Oncology Clinical Trial Assay Development – Broadcast 2

January 22, 2019

From Biomarkers to Companion Diagnostics: Advances in Immuno-Oncology Clinical Trial Assay Development – Broadcast 1

January 22, 2019

Ligand Binding Assays and Hybrid LC-MS Quantitation of Biotherapeutics and Biomarkers

December 03, 2018

Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials

October 22, 2018

Identifying Spatial Expression Patterns in the Tumor Microenvironment – Broadcast 2

October 09, 2018

Identifying Spatial Expression Patterns in the Tumor Microenvironment – Broadcast 1

October 09, 2018

Here’s Why Brain Biomarkers of Alzheimer’s Don’t Always Lead to Dementia

August 20, 2018

New Method Collects Circulating Tumor Cells from Blood Samples to be Used in Liquid Biopsy

Next Page »